Synthesis and use of an amphiphilic dendrimer for siRNA delivery into primary immune cells

Jiaxuan Chen, Aleksandra Ellert-Miklaszewska, Stefano Garofalo, Arindam K. Dey, Jingjie Tang, Yifan Jiang, Flora Clément, Patrice N. Marche, Xiaoxuan Liu, Bozena Kaminska, Angela Santoni, Cristina Limatola, John J. Rossi, Jiehua Zhou, Ling Peng

Published: 2020-12-03 DOI: 10.1038/s41596-020-00418-9

amphiphilic dendrimer

siRNA delivery

primary immune cells

functional siRNA delivery

immune system manipulation

AI 解读

Using high-resolution microscopy data to generate realistic structures for electromagnetic FDTD simulations from complex biological models

Experimental modulation of physiological force application on leg joint neurons in intactDrosophila melanogaster

Mitochondrial single-cell ATAC-seq for high-throughput multi-omic detection of mitochondrial genotypes and chromatin accessibility

Identification, isolation and analysis of human gut-associated lymphoid tissues

Development of RNA G-quadruplex (rG4)-targetingl-RNA aptamers by rG4-SELEX

Self-assembled ultraflexible probes for long-term neural recordings and neuromodulation

Hyperpolarized water as universal sensitivity booster in biomolecular NMR

Improved sampling and DNA extraction procedures for microbiome analysis in food-processing environments

An analytical workflow for dynamic characterization and quantification of metal-bearing nanomaterials in biological matrices

A flow cytometry-based protocol for syngenic isolation of neurovascular unit cells from mouse and human tissues

查看全部

Sections

Figures

References

Using siRNAs to genetically manipulate immune cells is important to both basic immunological studies and therapeutic applications. However, siRNA delivery is challenging because primary immune cells are often sensitive to the delivery materials and genera
Introduction
Materials
Procedure
Troubleshooting
Timing
Anticipated results
- Reporting Summary
References
ACKNOWLEDGMENTS

Wilson, R. C. & Doudna, J. A. Molecular mechanisms of RNA interference. Annu. Rev. Biophys. 42, 217–239 (2013).
Kim, D. & Rossi, J. RNAi mechanisms and applications. Biotechniques 44, 613–616 (2008).
Setten, R. L., Rossi, J. J. & Han, S. P. The current state and future directions of RNAi-based therapeutics. Nat. Rev. Drug Discov. 18, 421–446 (2019).
Sioud, M. Releasing the immune system brakes using siRNAs enhances cancer immunotherapy. Cancers (Basel) 11, 176 (2019).
Riley, R. S., June, C. H., Langer, R. & Mitchell, M. J. Delivery technologies for cancer immunotherapy. Nat. Rev. Drug Discov. 18, 175–196 (2019).
Kanasty, R., Dorkin, J. R., Vegas, A. & Anderson, D. Delivery materials for siRNA therapeutics. Nat. Mater. 12, 967–977 (2013).
Whitehead, K. A., Langer, R. & Anderson, D. G. Knocking down barriers: advances in siRNA delivery. Nat. Rev. Drug Discov. 8, 129–138 (2009).
Judge, A. D. et al. Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nat. Biotechnol. 23, 457–462 (2005).
Judge, A. & MacLachlan, I. Overcoming the innate immune response to small interfering RNA. Hum. Gene Ther. 19, 111–124 (2008).
Whitehead, K. A., Dahlman, J. E., Langer, R. S. & Anderson, D. G. Silencing or stimulation? siRNA delivery and the immune system. Annu. Rev. Chem. Biomol. Eng. 2, 77–96 (2011).
Zhang, X., Edwards, J. P. & Mosser, D. M. The expression of exogenous genes in macrophages: obstacles and opportunities. Methods Mol. Biol. 531, 123–143 (2009).
Freeley, M. & Long, A. Advances in siRNA delivery to T-cells: potential clinical applications for inflammatory disease, cancer and infection. Biochem. J. 455, 133–147 (2013).
Nakamura, T. et al. Small-sized, stable lipid nanoparticle for the efficient delivery of siRNA to human immune cell lines. Sci. Rep. 6, 37849 (2016).
Nakamura, T., Yamada, K., Fujiwara, Y., Sato, Y. & Harashima, H. Reducing the cytotoxicity of lipid nanoparticles associated with a fusogenic cationic lipid in a natural killer cell line by introducing a polycation-based siRNA core. Mol. Pharmaceutics 15, 2142–2150 (2018).
Davis, M. E. et al. Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 464, 1067–1070 (2010).
Yu, T. et al. An amphiphilic dendrimer for effective delivery of small interfering RNA and gene silencing in vitro and in vivo. Angew. Chem. Int. Ed. Engl. 51, 8478–8484 (2012).
Liu, X. X. et al. Adaptive amphiphilic dendrimer-based nanoassemblies as robust and versatile siRNA delivery systems. Angew. Chem. Int. Ed. Engl 53, 11822–11827 (2014).
Chen, C. et al. Mastering dendrimer self-assembly for efficient siRNA delivery: from conceptual design to in vivo efficient gene silencing. Small 12, 3667–3676 (2016).
Dong, Y. et al. A dual targeting dendrimer-mediated siRNA Delivery system for effective gene silencing in cancer therapy. J. Am. Chem. Soc. 140, 16264–16274 (2018).
Ellert-Miklaszewska, A. et al. Efficient and innocuous delivery of small interfering RNA to microglia using an amphiphilic dendrimer nanovector. Nanomedicine (Lond.) 14, 2441–2458 (2019).
Garofalo, S. et al. Natural killer cells modulate motor neuron-immune cell cross talk in models of amyotrophic lateral sclerosis. Nat. Commun. 11, 1773 (2020).
Kim, D. H. et al. Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy. Nat. Biotechnol. 23, 222–226 (2005).
Amarzguioui, M. et al. Rational design and in vitro and in vivo delivery of Dicer substrate siRNA. Nat. Protoc. 1, 508–517 (2006).
Tomalia, D. A. et al. A new class of polymers - starburst-dendritic macromolecules. Polym. J. 17, 117–132 (1985).
Peterson, J., Allikmaa, V., Subbi, J., Pehk, T. & Lopp, M. Structural deviations in poly(amidoamine) dendrimers: a MALDI-TOF MS analysis. Eur. Polym. J. 39, 33–42 (2003).
van Dongen, M. A., Desai, A., Orr, B. G., Baker, J. R. & Holl, M. M. B. Quantitative analysis of generation and branch defects in G5 poly(amidoamine) dendrimer. Polymer 54, 4126–4133 (2013).
Rastogi, A. & Nayan, R. Studies on copper (II) complexes of some polyaza macrocycles derived from 1, 2-diaminoethane. J. Coord. Chem. 62, 3366–3376 (2009).
Trouplin, V. et al. Bone marrow-derived macrophage production. J. Vis. Exp 2013, e50966 (2013).
Armarego, W. L. F. & Perrin, D. D. Purification of Laboratory Chemicals (Butterworth Heinemann, 1996).
Vogel, A. I., Furniss, B. S., Hannaford, A. J., Smith, P. W. & Tatchell, A. R. Vogel’s Textbook of Practical Organic Chemistry (Longman Scientific & Technical, 1989).
Fauci, A. S. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science 239, 617–622 (1988).
Frankel, A. D. & Young, J. A. HIV-1: fifteen proteins and an RNA. Annu. Rev. Biochem. 67, 1–25 (1998).
Molfetta, R., Quatrini, L., Santoni, A. & Paolini, R. Regulation of NKG2D-dependent NK cell functions: the yin and the yang of receptor endocytosis. Int. J. Mol. Sci. 18, 1677 (2017).
Malemud, C. J. The role of the JAK/STAT signal pathway in rheumatoid arthritis. Ther. Adv. Musculoskelet. Dis. 10, 117–127 (2018).
De Vries, L. C. S., Wildenberg, M. E., De Jonge, W. J. & D’Haens, G. R. The future of Janus kinase inhibitors in inflammatory bowel disease. J. Crohns Colitis 11, 885–893 (2017).
Triyangkulsri, K. & Suchonwanit, P. Role of Janus kinase inhibitors in the treatment of alopecia areata. Drug Des. Devel. Ther. 12, 2323–2335 (2018).
Guo, X. et al. Transfection reagent Lipofectamine triggers type I interferon signaling activation in macrophages. Immunol. Cell Biol. 97, 92–96 (2019).
Papaspyridonos, M. et al. Id1 suppresses anti-tumour immune responses and promotes tumour progression by impairing myeloid cell maturation. Nat. Commun. 6, 6840 (2015).
Zebedee, Z. & Hara, E. Id proteins in cell cycle control and cellular senescence. Oncogene 20, 8317–8325 (2001).

Synthesis and use of an amphiphilic dendrimer for siRNA delivery into primary immune cells

Supplementary information

推荐阅读